Loading live market data…

Arrowhead Pharmaceuticals, Inc.

NASDAQ:ARWR

$71.265 USD

-$0.65 (-0.9%)

Volume
1.11M
Average Volume
2.09M
Market Capitalization
$10.04B
P/E Ratio
-33.30
Dividend Yield
0.00%
Price Target
$94.00
Year High
$87.83
Year Low
$14.30
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$6.23

ARWR Estimated and Actual Revenue by Quarter

ARWR Estimated and Actual EPS by Quarter

ARWR Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-09-30 4 -215.48M -29.25M -105.28M -226.73M -30.78M -110.78M
2027-06-30 6 -54.01M -7.33M -26.39M -56.84M -7.72M -27.77M
2027-03-31 4 -50.07M -6.8M -24.47M -52.69M -7.15M -25.74M
2026-12-31 7 -72.23M -9.81M -35.29M -76.01M -10.32M -37.14M
2026-09-30 8 -94.36M -16.67M -48.03M -99.29M -17.54M -50.54M
2026-06-30 8 -89.36M -7.64M -31.62M -94.02M -8.04M -33.27M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-09-30 4 -189.95M -4.92M -80.47M 267.65M 1.97B 963.4M
2027-06-30 6 -423.6M -10.97M -179.45M 67.09M 494.25M 241.5M
2027-03-31 4 -420.23M -10.89M -178.02M 62.2M 458.19M 223.88M
2026-12-31 7 -379.89M -9.84M -160.93M 89.72M 660.97M 322.96M
2026-09-30 8 -198.81M -97.43M -159.31M 152.57M 863.42M 439.51M
2026-06-30 8 -224.06M -38.84M -173.27M 69.88M 817.65M 289.32M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-09-30 4 46.33M 341.27M 166.75M 3 -1.33373 -0.03455523 -0.565
2027-06-30 6 11.61M 85.55M 41.8M 5 -2.97434 -0.07706121 -1.26
2027-03-31 4 10.77M 79.31M 38.75M 3 -2.95073 -0.07644961 -1.25
2026-12-31 7 15.53M 114.41M 55.9M 6 -2.66746 -0.06911045 -1.13
2026-09-30 8 26.41M 149.45M 76.07M 8 -1.39599 -0.68413 -1.11864
2026-06-30 8 12.1M 141.52M 50.08M 8 -1.57325 -0.2727 -1.21665